Snowball logo
logo
ANTH_logo

Anthera Pharmaceuticals Inc

ANTH • PINK
$0.0001$0.00  (0%)
Estimate
Beta
-65.789
About the company
Ticker
ANTH
ISIN
US03674U3005
Country
United States of America
Sector (GICS)
Healthcare
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

Frequently asked questions

What sector does Anthera Pharmaceuticals Inc (ANTH) operate in?

Anthera Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Anthera Pharmaceuticals Inc (ANTH) current stock price?

As of the latest data, Anthera Pharmaceuticals Inc stock price is $0.00, with a previous close of $0.00.

What is Anthera Pharmaceuticals Inc (ANTH) current market capitalization?

Anthera Pharmaceuticals Inc market cap is approximately 2.62 thousand.

Does Anthera Pharmaceuticals Inc (ANTH) pay dividends?

No. Anthera Pharmaceuticals Inc does not pay a dividend.

What is Anthera Pharmaceuticals Inc (ANTH) beta (volatility) score?

Anthera Pharmaceuticals Inc has a beta of -65.789, indicating lower volatility than the overall market.